Point72 Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Point72 Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-91,761	Closed	-$574K	–	1827
2022 Q2	$574K	Sell	91,761 -758,239	-89%	-$2.55M	﹤0.01%	1162
2022 Q1	$3.02M	Sell	850,000 -131,249	-13%	-$485K	0.01%	807
2021 Q4	$4.93M	Hold	981,249	–	–	0.02%	675
2021 Q3	$7.18M	Sell	981,249 -93,751	-9%	-$643K	0.03%	572
2021 Q2	$9.23M	Buy	1,075,000 +1,000,000	+1,333%	+$8.53M	0.04%	472
2021 Q1	$812K	Buy	+75,000	New	+$728K	﹤0.01%	827

Other funds holding FSTX

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management's FSTX Position: Q3 2022 in Review

Point72 Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2022, closing a stake of 91,761 shares — an estimated $574K sold.

Point72 Asset Management first reported a position in FSTX in Q1 2021 and held it in 6 quarters. The position peaked at $9.23M in Q2 2021. 54 funds tracked by Wall St. Rank hold FSTX as of Q3 2022.

Point72 Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Point72 Asset Management sold 91,761 F-star Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $574K.
Point72 Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Point72 Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $9.23M in Q2 2021.
54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Point72 Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.